Skip to main
AFL

Aflac (AFL) Stock Forecast & Price Target

Aflac (AFL) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 0%
Buy 15%
Hold 54%
Sell 31%
Strong Sell 0%

Bulls say

Aflac is expected to see growth in its Japan segment, which generates the highest revenue for the company, due to the launch of its Anshin Palette medical insurance product and the continued momentum of its Tsumitasu product. The company also aims to increase its cross-selling efforts to drive sales in the Japan market. Furthermore, net investment income increase and focus on maintaining profitability also provide a positive outlook for the company.

Bears say

Aflac is showing signs of struggle in both the US and Japan segments, with lower than expected net earned premiums and a decline in the corporate and other segment. The company's mergers and acquisitions strategy may be a cause for concern as they continue to look for growth opportunities. While the persistency rate in the US remains strong, the company's sales in Japan have been delayed and it is uncertain if they will be able to achieve their goal of $80 billion JPY in sales by 2026.

Aflac (AFL) has been analyzed by 13 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 15% recommend Buy, 54% suggest Holding, 31% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aflac and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aflac (AFL) Forecast

Analysts have given Aflac (AFL) a Hold based on their latest research and market trends.

According to 13 analysts, Aflac (AFL) has a Hold consensus rating as of Sep 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $116.92, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $116.92, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aflac (AFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.